🇺🇸 FDA
Pipeline program

Injection of IAH0968+Gemcitabine+Cisplatin

IAH0968-201

Phase 2 other active

Quick answer

Injection of IAH0968+Gemcitabine+Cisplatin for HER2 Gene Mutation is a Phase 2 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
HER2 Gene Mutation
Phase
Phase 2
Modality
other
Status
active

Clinical trials